Design Therapeutics, Inc. (DSGN)

Design Therapeutics Statistics

Total Valuation

DSGN has a market cap or net worth of $533.75 million. The enterprise value is $329.52 million.

Market Cap	533.75M
Enterprise Value	329.52M

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

DSGN has 56.96 million shares outstanding. The number of shares has increased by 0.66% in one year.

Current Share Class	56.96M
Shares Outstanding	56.96M
Shares Change (YoY)	+0.66%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	15.49%
Owned by Institutions (%)	41.32%
Float	26.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.67
P/TBV Ratio	2.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.71, with a Debt / Equity ratio of 0.01.

Current Ratio	18.71
Quick Ratio	18.56
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.83% and return on invested capital (ROIC) is -21.25%.

Return on Equity (ROE)	-29.83%
Return on Assets (ROA)	-20.49%
Return on Invested Capital (ROIC)	-21.25%
Return on Capital Employed (ROCE)	-38.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.25M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.73% in the last 52 weeks. The beta is 1.68, so DSGN's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	+66.73%
50-Day Moving Average	6.83
200-Day Moving Average	4.94
Relative Strength Index (RSI)	72.72
Average Volume (20 Days)	455,493

Short Selling Information

The latest short interest is 2.00 million, so 3.52% of the outstanding shares have been sold short.

Short Interest	2.00M
Short Previous Month	1.85M
Short % of Shares Out	3.52%
Short % of Float	7.54%
Short Ratio (days to cover)	5.39

Income Statement

Revenue	n/a
Gross Profit	-57.86M
Operating Income	-77.59M
Pretax Income	-67.45M
Net Income	-67.45M
EBITDA	-76.98M
EBIT	-77.59M
Earnings Per Share (EPS)	-$1.19

Balance Sheet

The company has $205.97 million in cash and $1.74 million in debt, giving a net cash position of $204.23 million or $3.59 per share.

Cash & Cash Equivalents	205.97M
Total Debt	1.74M
Net Cash	204.23M
Net Cash Per Share	$3.59
Equity (Book Value)	199.72M
Book Value Per Share	3.51
Working Capital	197.86M

Cash Flow

In the last 12 months, operating cash flow was -$52.25 million and capital expenditures -$159,000, giving a free cash flow of -$52.41 million.

Operating Cash Flow	-52.25M
Capital Expenditures	-159,000
Free Cash Flow	-52.41M
FCF Per Share	-$0.92

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.66%
Shareholder Yield	-0.66%
Earnings Yield	-12.64%
FCF Yield	-9.82%

Analyst Forecast

The average price target for DSGN is $13.00, which is 38.74% higher than the current price. The consensus rating is "Buy".

Price Target	$13.00
Price Target Difference	38.74%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	7.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1